Stocks Boston Scientific Corp

More

  • Over the past several years, the FDA has received thousands of reports of complications, including bleeding, organ perforation and urinary problems, involving the use of mesh for transvaginal POP repair, the agency said. The FDA noted that an advisory panel of experts in 2011 recommended that more data was needed to establish their safety.

  • BOSTON, Dec 21- Boston College graduates know how to pick stocks. The Boston College graduates, now picking stocks for a living, won with bets that include Clearwater Paper, which rose 356 percent between 2009 when it was first pitched and 2013 when the position was closed. Other top performing selections by Boston College graduates include Boston Scientific,...

  • Shares of medtech companies such as Edwards Lifesciences, Boston Scientific and Becton Dickinson have outperformed the broad healthcare sector, and especially pharmaceutical and biotech shares, over the past two months since U.S. presidential candidate Hillary Clinton tweeted she planned to address specialty drug "price gouging." He said he likes...

  • Medtronic Plc, Abbott Laboratories, Edwards Lifesciences Corp and HeartWare International Inc in recent months have spent a total of $2 billion to buy young companies developing versions of the technology. Nearly 6 million people in the United States may suffer from mitral disease, and Wall Street analysts say it could be the next multibillion-dollar...

  • *Retailers fall after Macy's cuts forecasts. Nov 11- U.S. stock indexes were little changed in muted afternoon trading on Wednesday as investors bought into tech and industrial stocks after selling retailers earlier in the session after a disappointing full-year forecast from Macy's. Amazon was up 2.2 percent at $674.10, providing the biggest boost to the S&P...

  • *Retailers fall after Macy's cuts forecasts. Nov 11- Wall Street was slightly lower in choppy trading on Wednesday, as a drop in oil prices weighed on energy stocks and disappointing results from Macy's pummeled retailers. Macy's fell as much as 14.7 percent to $40.10 after the company reported a 3.6 percent drop in quarterly same-store sales and slashed its...

  • *Alibaba up after strong Singles' Day sales reports. Nov 11- U.S. stocks were little changed in choppy early trading on Wednesday after data from China appeared to make a case for further stimulus measures from Beijing, while investors braced for a possible hike in U.S. interest rates next month. E-commerce giant Alibaba provided further evidence that the Chinese...

  • ORLANDO, Fla., Nov 9- Patients with severe leakage from the mitral valve of the heart who had the valve replaced had significantly lower rates of recurrence and heart failure two years after the procedure than those who underwent surgical repair, according to data presented on Monday. There was also a higher rate of reported heart failure events, 48 versus 29, and...

  • Early movers: DMND, ANTM, GNRC, HLT, HOT & more Wednesday, 28 Oct 2015 | 7:51 AM ET
    Traders work on the floor of the New York Stock Exchange.

    Some of the names on the move ahead of the open.

  • Oct 28- Medical device maker Boston Scientific Corp reported a better-than-expected quarterly profit, helped by strong demand for its surgical products. Boston Scientific's MedSurg unit- which makes surgical products, excluding those for the heart- notched sales growth of 17.5 percent in the quarter. Boston Scientific said total revenue increased 9...

  • Boston Scientific's revenue rises about 2 pct Wednesday, 28 Oct 2015 | 6:44 AM ET

    Oct 28- Medical device maker Boston Scientific Corp reported a 2.3 percent rise in quarterly revenue as sales rose in all three of its divisions. The company posted a net loss of $198 million, or 15 cents per share, in the third quarter ended Sept. 30, compared with net profit of $43 million, or 3 cents per share, a year earlier. Revenue rose to $1.89 billion from $1.85...

  • Oct 12- A novel dissolving heart stent developed by Abbott Laboratories proved comparably safe and effective as its market-leading Xience stent in a large, late-stage trial that will be used to seek U.S. approval of the device, according to data presented at a medical meeting on Monday. The bioabsorbable Absorb stent succeeded in demonstrating...

  • NEW YORK, Oct 9- A Delaware judge on Friday said Boston Scientific should only have to pay $10 million to a woman originally awarded $100 million by a jury who found she was injured by transvaginal mesh, a device that is the subject of thousands of lawsuits. But Johnston denied Boston Scientific's bid to set aside the verdict altogether and order a new trial.

  • In an Aug. 31 filing in federal court in Toledo, Ohio, the defendant asked the court to compel MedStar to turn over more information about the liens, so it can investigate whether the funder schemed to "artificially inflate damages claims." According to DePuy, MedStar submitted claims for nearly $1.5 million for 11 surgeries that should have cost no more than...

  • Trader: Where to find value in the selloff Wednesday, 2 Sep 2015 | 7:11 AM ET
    TJ Maxx TK Maxx stores

    Aureus Asset Management CEO Karen Firestone says there's value in U.S.-centric consumer and health-care stocks.

  • Aug 19- Medical device maker Boston Scientific Inc said its stent to prevent the blocking of arteries in the legs was approved in the United States, four years after the device was recalled outside the country due to partial or no deployments. Boston Scientific also develops another medical device called Eluvia Stent that uses Innova's technology and is...

  • NEW YORK, Aug 18- In July 2013, California urogynecologist Andrew Cassidenti received an email from an entrepreneur named Otto Fisher, who had a proposition. In a phone call, Fisher said he needed doctors to operate at outpatient centers in California and Las Vegas. Fisher said he could guarantee Cassidenti $2,500 for every surgery the doctor performed, "whether...

  • America's top states for innovation in 2015 Wednesday, 24 Jun 2015 | 4:30 PM ET
    Top States Technology and Innovation

    These 10 states lead the nation in tech investment, patents and research, which has helped reinvigorate their local economies.

  • Are 'phony numbers' misleading investors? Monday, 8 Jun 2015 | 7:04 AM ET
    Traders work on the floor of the New York Stock Exchange.

    Those record profits that companies are reporting may not be all they're cracked up to be.

  • Biotech isn't only health-care bet beating market Monday, 1 Jun 2015 | 10:09 AM ET
    An employee works on a stent graft component in a sterile environment at the Medtronic assembly plant in Tijuana, Mexico.

    The health-care sector is hot, and investors don't have to bet on the riskiest biotech stocks to profit.